![]() |
Volumn 15, Issue 2, 2001, Pages 300-302
|
Endocannabinoids control spasticity in a multiple sclerosis model.
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 ARACHIDONOYLGLYCEROL;
2-ARACHIDONYLGLYCEROL;
ACYLGLYCEROL;
AMIDE;
ANANDAMIDE;
ARACHIDONIC ACID DERIVATIVE;
CANNABINOID;
CANNABINOID RECEPTOR;
DRUG RECEPTOR;
ENDOCANNABINOID;
N (4 HYDROXYPHENYL)ARACHIDONYLAMIDE;
N-(4-HYDROXYPHENYL)ARACHIDONYLAMIDE;
PALMIDROL;
PALMITIC ACID DERIVATIVE;
PIPERIDINE DERIVATIVE;
PYRAZOLE DERIVATIVE;
RIMONABANT;
ALLERGIC ENCEPHALOMYELITIS;
ANIMAL;
ARTICLE;
BRAIN;
DISEASE MODEL;
DRUG ANTAGONISM;
HUMAN;
METABOLISM;
MOUSE;
MOUSE STRAIN;
MULTIPLE SCLEROSIS;
MUSCLE SPASM;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
SPINAL CORD;
ANIMALS;
ARACHIDONIC ACIDS;
BRAIN;
CANNABINOIDS;
DISEASE MODELS, ANIMAL;
ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL;
ENDOCANNABINOIDS;
GLYCERIDES;
HUMANS;
MICE;
MICE, INBRED STRAINS;
MULTIPLE SCLEROSIS;
PALMITIC ACIDS;
PIPERIDINES;
POLYUNSATURATED ALKAMIDES;
PYRAZOLES;
RECEPTORS, CANNABINOID;
RECEPTORS, DRUG;
SPASM;
SPINAL CORD;
MLCS;
MLOWN;
|
EID: 0035256557
PISSN: 08926638
EISSN: None
Source Type: Journal
DOI: 10.1096/fj.00-0399fje Document Type: Article |
Times cited : (372)
|
References (0)
|